Stage IV Head and Neck Cancer
Also known as: Head and neck cancer stage IV / Metastatic Head and Neck Carcinoma
Drug | Drug Name | Drug Description |
---|
Drug | Drug Name | Target | Type |
---|
Drug | Drug Name | Phase | Status | Count |
---|---|---|---|---|
DB00112 | Bevacizumab | 1 | Completed | 1 |
DB00112 | Bevacizumab | 1 | Recruiting | 1 |
DB08875 | Cabozantinib | 1 | Active Not Recruiting | 1 |
DB00515 | Cisplatin | 1 | Completed | 1 |
DB00531 | Cyclophosphamide | 1 | Recruiting | 1 |
DB01248 | Docetaxel | 1 | Completed | 1 |
DB00530 | Erlotinib | 1 | Completed | 1 |
DB17474 | Exlinkibart | 1 | Recruiting | 1 |
DB00544 | Fluorouracil | 1 | Recruiting | 1 |
DB01005 | Hydroxyurea | 1 | Recruiting | 1 |
DB09035 | Nivolumab | 1 | Active Not Recruiting | 1 |
DB01229 | Paclitaxel | 1 | Recruiting | 1 |
DB14769 | Pamiparib | 1 | Recruiting | 1 |
DB14922 | Tislelizumab | 1 | Recruiting | 1 |
DB09037 | Pembrolizumab | 1 / 2 | Recruiting | 1 |
DB08875 | Cabozantinib | 2 | Active Not Recruiting | 1 |
DB00002 | Cetuximab | 2 | Active Not Recruiting | 1 |
DB16296 | IPI-549 | 2 | Recruiting | 1 |
DB14933 | Nicotinamide riboside | 2 | Terminated | 1 |
DB09035 | Nivolumab | 2 | Active Not Recruiting | 1 |
DB01229 | Paclitaxel | 2 | Active Not Recruiting | 1 |
DB09037 | Pembrolizumab | 2 | Active Not Recruiting | 2 |
DB09037 | Pembrolizumab | 2 | Recruiting | 1 |
DB14797 | SEphB4-HSA | 2 | Active Not Recruiting | 1 |
DB00820 | Tadalafil | 2 | Recruiting | 1 |